Efficient Predictor for Immunotherapy Efficacy: Detecting Pan‐Clones Effector Tumor Antigen‐Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens
Abstract Cancer involves tumor cells and tumor‐specific immunity. The ability to accurately quantify tumor‐specific immunity is limited. Most immunotherapies function by activating new effector tumor antigen‐specific T cells (ETASTs) or reactivating the pre‐existing ETASTs repertoire. Therefore, the...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202409913 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|